SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Incyte Corporation (INCY)

INCY RSS Feed
Add INCY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/16/2016 5:26:48 PM - Followers: 22 - Board type: Free - Posts Today: 0
http://www.incyte.com/

http://finance.yahoo.com/q/ks?s=INCY

http://www.form4oracle.com/company?cik=0000879169&ticker=incy

Incyte Corporation is a drug discovery and development company, which focuses on developing proprietary small molecule drugs to treat human immunodeficiency virus (HIV), diabetes, oncology, and inflammation diseases. The company's CCR2 program is being developed under collaboration with Pfizer, Inc. for inflammatory diseases. Its pipeline also includes sheddase inhibitor (INCB7839), which is in phase IIa clinical trials for solid tumors; CCR5 antagonists for HIV, including INCB9471 in phase IIa and INCB15050 in phase I clinical trials; and 11�HSD1 inhibitor (INCB13739), which is in phase IIa clinical trial for type 2 diabetes. The company also has preclinical programs under development, such as JAK 2 Program for inflammatory diseases, myeloproliferative disorders, and cancer. Incyte offers its products in the United States, Canada, Germany, Sweden, and the United Kingdom. The company was founded in 1991 and is headquartered in Wilmington, Delaware.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INCY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
INCY News: Statement of Changes in Beneficial Ownership (4) 11/17/2016 04:31:15 PM
INCY News: Baricitinib Demonstrates Early Response Compared to Placebo and Significant Improvement Compared to Adalimumab in Patient-Rep... 11/14/2016 09:00:00 AM
INCY News: Baricitinib Demonstrates Early Response Compared to Placebo and Significant Improvement Compared to Adalimumab in Patient-Rep... 11/14/2016 09:00:00 AM
INCY News: New Analyses of Phase 3 Trials Show Improvements in Rheumatoid Arthritis Symptoms Following Treatment with Baricitinib Across... 11/14/2016 09:00:00 AM
INCY News: New Analyses of Phase 3 Trials Show Improvements in Rheumatoid Arthritis Symptoms Following Treatment with Baricitinib Across... 11/14/2016 09:00:00 AM
PostSubject
#174   (Good news for INCY)—GILD’s Momelotinib goes 1-for-2 in DewDiligence 11/16/16 05:26:48 PM
#173   What's going on today?? new investments 11/09/16 09:56:23 AM
#172   Incyte Corp fundamental analysis highlights shares are ~15% ValueInvestor15 10/31/16 02:32:03 PM
#171   Hello!? Hello?! Invest83838 08/23/16 05:39:47 PM
#170   Watching this closely now. inversor86 01/29/16 02:44:20 AM
#169   INCY 10 MINUTES TREND1 11/21/15 06:18:37 PM
#168   Cowen and Jefferis are out with reports defending magness 11/06/15 02:35:11 PM
#167   44% swing in one week. Crazy! 4starman 10/02/15 04:14:03 PM
#166   $INCY recent news/filings stocktrademan 08/30/15 09:56:08 AM
#165   FLOAT = 137M TREND1 07/31/15 01:45:49 PM
#164   INCY W TREND1 07/22/15 03:51:22 PM
#163   INCY 30 MINUTES TREND1 07/17/15 01:21:59 PM
#162   THE CHARTIST follows this stock. TREND1 07/17/15 01:18:25 PM
#161   Inst % Owned = 95% TREND1 07/17/15 01:17:02 PM
#160   INCY W TREND1 07/16/15 11:09:34 PM
#159   $INCY DD Notes ~ http://www.ddnotesmaker.com/INCY stocktrademan 12/12/14 12:27:11 PM
#158   $INCY DD Notes ~ http://www.ddnotesmaker.com/INCY stocktrademan 10/29/14 09:28:11 AM
#157   INCY LABEL EXPANSION NEWS [SMART MONEY] 07/28/14 08:35:53 AM
#156   12:45PM Incyte: Jakafi (ruxolitinib) continues to show improved surf1944 12/09/13 02:13:54 PM
#155   2:13AM Incyte presents positive results from proof-of-concept Phase surf1944 10/29/13 09:44:13 AM
#154   investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=1850254&hig FreeNorth 09/02/13 01:27:06 AM
#153   Mid-stage trial promising: Up almost $9 http://www.reuters.com/article/2013/08/2 mlkrborn 08/21/13 01:51:37 PM
#152   7:00AM Incyte provides top-line results from Phase II surf1944 08/21/13 09:18:50 AM
#151   Presentation at wells fargo ECole 07/16/13 07:46:34 AM
#148   6:03AM Eli Lilly and Incyte (INCY) announce Baricitinib surf1944 06/13/13 09:43:02 AM
#147   1:40AM Incyte presents final results from a Phase surf1944 06/03/13 09:43:29 AM
#146   Does anyone have any comments on "Coverage resumed WID 05/07/13 09:51:20 AM
#145   7:09AM Incyte beats by $0.06, beats on revs surf1944 05/02/13 08:30:35 AM
#144   8:01AM Incyte achieves $50 mln milestone as Oral surf1944 11/15/12 09:37:19 AM
#143   Ok surf...tell me what trashed the shares causing biomanbaba 09/03/12 01:48:34 PM
#142   7:05AM Incyte beats by $0.05, beats on revs surf1944 08/02/12 08:54:54 AM
#141   8. Incyte Corporation (INCY): Focuses on the discovery surf1944 07/10/12 11:23:52 AM
#140   ~ Thursday! $INCY ~ Q1 Earnings posted, pending Penny Roger$ 04/26/12 08:34:13 AM
#139   <<< $INCY Links! >>> ~ MAC's Quick DD Penny Roger$ 04/26/12 08:33:50 AM
#138   9:26AM Incyte announces EU regulatory milestone for ruxolitinib, surf1944 04/20/12 10:28:54 AM
#137   5:04PM Incyte announces that Phase III studies of surf1944 03/01/12 05:57:25 AM
#136   ~ $INCY ~ Earnings posted, pending or coming Penny Roger$ 02/07/12 12:52:22 AM
#135   Analysis: Investors likely to wait out 2012 drug launches surf1944 01/13/12 04:55:20 PM
#134   Thanks friend ! Good Luck here.... afxm 12/09/11 12:04:57 AM
#133   approval and launching are both important: mlkrborn 12/05/11 05:12:15 PM
#132   approved earlier. mlkrborn 12/05/11 05:07:03 PM
#131   Were they expecting fda approval for a drug afxm 12/05/11 12:47:58 AM
#130   you bet ! Is INCY expecting news monday ? afxm 12/05/11 12:38:18 AM
#129   afxm; good u r alive & kicking! mlkrborn 12/04/11 10:07:50 PM
#128   MSN Money stockscouter has a rating of 8 afxm 12/04/11 09:21:38 PM
#127   Insider Felix Baker has been buying this like afxm 12/04/11 08:56:10 PM
#126   $13.69 with approval news: mlkrborn 11/16/11 12:17:40 PM
#125   Another FDA approval not long ago from ALRT. GrandeS 11/16/11 11:51:32 AM
#124   Zecco showing a bid of 14.45 Chimaera 11/16/11 11:44:00 AM
#123   Approval has been announced by the FDA. GrandeS 11/16/11 11:33:06 AM
PostSubject